It has been shown that in MLL-AF9-induced murine AML, deletion of AMPK, a positive regulator of autophagy, significantly delays leukemogenesis and depletes LSCs by reducing the expression of glucose transporter 1 (Glut1), compromising glucose flux, and increasing oxidative stress and DNA damage [56]. Here, SLC2A1 is linked to acute myeloid leukemia.